Back60 Degrees Pharmaceuticals- Warrants (16/05/2028) Overview
60 Degrees Pharmaceuticals Inc - Warrants (16/05/2028)

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Return on Equity

Valuation check: SXTPW's ROE is -320.9%, below the sector sector average of -5.68%.

Get informed when a big investor buys or sells

+ Follow

ROE

-320.90%

Return on Equity

-320.90%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) (SXTPW) FAQ

60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s return on equity stands at -320.9%. That is below the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

60 Degrees Pharmaceuticals- Warrants (16/05/2028) sits lower the its sector benchmark (-5.68%) with a ROE of -320.9%. That is roughly 5547.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of -320.9% for 60 Degrees Pharmaceuticals- Warrants (16/05/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s ROE evolved across reporting periods, while the comparison chart places SXTPW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.